Chemplast Sanmar Q4 Review - Customer Manufacturing Business’ Growth Visibility Stronger: ICICI Securities

ICICI Securities Report

Chemplast Sanmar Ltd.’s Q4 FY24 print was expected to be weak, owing to the PVC business continuing to struggle, start-up costs in the custom manufacturing business (new facility and products) and weak revenues from its existing portfolio.

The PVC business is poised to recover over the next few quarters, as spreads global normalise, and expects regulatory intervention to further aid spread for Indian producers.

The custom manufacturing business continues to show progress with the addition of a fourth LoI for new chemical entity AI in agrochemicals.

We cut our FY25E-26E Ebitda by 3-5%, but increase our SoTP-based target price to Rs 555 (versus Rs 550); as we increase Custom manufacturing’s FY26E enterprise value/Ebitda multiple to 22 times (from 20 times); and standalone EV/Ebitda multiple to nine times (from eight times). Maintain Buy.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.